Clinical trial
Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
NCT00021528 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00021528 |
|---|---|
| Title | Sequenced Treatment Alternatives to Relieve Depression (STAR*D) |
| Official title | Sequenced Treatment Alternatives to Relieve Depression |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Behavioral, Drug |
| Interventions | citalopram, BuproprionSR, buspirone, Lithium, mirtazapine, nortriptyline, sertraline, tranylcypromine, VenlafaxineXR, Cognitive Therapy and 1 more |
| Enrollment | 4,000 |
| Start date | Jul 1, 2001 |
| Completion | Sep 1, 2006 |
| First posted | Jul 23, 2001 |
| Last update posted | Sep 25, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: